Healthcare & Medical Devices Global On demand · 24-48h

Global Continuous Positive Airway Pressure (CPAP) Devices Market Strategic Research Report

Global Continuous Positive Airway Pressure (CPAP) Devices Ma…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Continuous Positive Airway Pressure (CPAP) Devices Market
$2.23B2025
7.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Fixed Pressure CPAP Device, Auto Adjusting CPAP Device

By Application: Hospital, Home Care

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ResMed, Philips, Fisher & Paykel Healthcare, BMC Medical, Wellell, Weinmann Emergency Medical, Breas Medical, SLS Medical Technology, Nidek Medical India, Hunan Beyond Medical, Somnetics, React Health, Resvent Medical, Elmaslar, Medicraft Medical Systems, Beijing Aeonmed, Topson Medical, Shenzhen Afkmed

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$2.23B
Billion USD
Forecast CAGR
7.9%
2025-2032
Forecast 2032
$3.8B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Continuous Positive Airway Pressure (CPAP) Devices market size is predicted to grow from US$ 2,228 million in 2025 to US$ 3,775 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.

Continuous positive airway pressure (CPAP) is a form of positive airway pressure (PAP) ventilation in which a constant level of pressure greater than atmospheric pressure is continuously applied to the upper respiratory tract of a person. The application of positive pressure may be intended to prevent upper airway collapse, as occurs in obstructive sleep apnea, or to reduce the work of breathing in conditions such as acute decompensated heart failure. CPAP therapy is highly effective for managing obstructive sleep apnea. Compliance and acceptance of use of CPAP therapy can be a limiting factor, with 8% of people stopping use after the first night and 50% within the first year.

Global key players of continuous positive airway pressure (CPAP) devices include ResMed, Philips, Fisher & Paykel Healthcare, Medtronic, Apex Medical, etc. Global top five manufacturers hold a share over 64%. The key players are mainly located in Europe, North America, China and Japan. In terms of product, fixed pressure CPAP is the largest segment, with a share over 54%. And in terms of application, the largest application is hospital, with a share over 66%, followed by home care.

The rise in the global prevalence of obstructive sleep apnea (OSA), largely driven by factors like obesity, aging populations, and lifestyle changes, is one of the primary factors fueling the demand for CPAP machines.

As more people are diagnosed with sleep apnea, the need for CPAP therapy is expected to increase globally, particularly in developed markets.

Smart CPAP Devices: CPAP machines are increasingly being integrated with smart technology, allowing for real-time data tracking and sharing with healthcare providers. This provides patients with valuable insights into their sleep quality and treatment efficacy.

Auto-adjusting CPAP Machines: Devices like AutoCPAP and Bi-level CPAP (BiPAP) offer automatic pressure adjustment during the night based on detected breathing patterns, which improves comfort and therapy effectiveness.

Noise Reduction: Manufacturers are focusing on reducing the noise levels of CPAP machines, as loud machines were a significant barrier to patient compliance. Quiet models are more comfortable for patients and partners.

Integrated Humidifiers: Many modern CPAP machines come with integrated heated humidifiers to prevent dryness in the nose and throat, which helps patients use the machine for longer periods.

The home healthcare market is growing rapidly, and patients are increasingly seeking at-home sleep apnea treatments due to the convenience and cost-effectiveness compared to hospital-based therapies.

Portable CPAP machines are gaining popularity, especially in the travel segment, as they are compact, lightweight, and battery-operated, allowing users to manage their sleep apnea treatment while on the go.

This report presents a comprehensive overview of the global Continuous Positive Airway Pressure (CPAP) Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Fixed Pressure CPAP Device
  • Auto Adjusting CPAP Device

Segment by Application

  • Hospital
  • Home Care

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Continuous Positive Airway Pressure (CPAP) Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Home Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Continuous Positive Airway Pressure (CPAP) Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.23B
2025
Forecast
$3.8B
2032
CAGR
7.9%
2025–2032
Regiones
5
global
Key companies
ResMedPhilipsFisher & Paykel HealthcareBMC MedicalWellellWeinmann Emergency MedicalBreas MedicalSLS Medical Technology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Fixed Pressure CPAP DeviceAuto Adjusting CPAP Device
By Application
HospitalHome Care

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Fixed Pressure CPAP Device
  • 3.1.3 Auto Adjusting CPAP Device
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Home Care
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ResMed
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Philips
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Fisher & Paykel Healthcare
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 BMC Medical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Wellell
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Weinmann Emergency Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Breas Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SLS Medical Technology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Nidek Medical India
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Hunan Beyond Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Somnetics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 React Health
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Resvent Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Elmaslar
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Medicraft Medical Systems
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Beijing Aeonmed
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Topson Medical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shenzhen Afkmed
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Continuous Positive Airway Pressure (CPAP) Devices market?
The global Continuous Positive Airway Pressure (CPAP) Devices market is estimated at US$ 2.23 billion in 2025 (base year) and is projected to reach US$ 3.77 billion by 2032.
How fast is the Continuous Positive Airway Pressure (CPAP) Devices market expected to grow?
The market is expected to grow at a CAGR of 7.9% from 2026 to 2032, expanding from US$ 2.23 billion in 2025 to US$ 3.77 billion in 2032, roughly 1.7 times its base-year value.
What does the Continuous Positive Airway Pressure (CPAP) Devices market cover?
Continuous positive airway pressure (CPAP) is a form of positive airway pressure (PAP) ventilation in which a constant level of pressure greater than atmospheric pressure is continuously applied to the upper respiratory tract of a person. The application of positive pressure may be intended to prevent upper airway collapse, as occurs in obstructive sleep apnea, or to reduce the work of breathing in conditions such as acute decompensated heart failure. CPAP therapy is highly effective for managing obstructive sleep apnea.
How is the Continuous Positive Airway Pressure (CPAP) Devices market segmented by type?
By type, the market is segmented into Fixed Pressure CPAP Device and Auto Adjusting CPAP Device.
What are the key applications of Continuous Positive Airway Pressure (CPAP) Devices?
Key applications covered include Hospital and Home Care.
Which companies are profiled in the Continuous Positive Airway Pressure (CPAP) Devices market report?
Key players profiled include ResMed, Philips, Fisher & Paykel Healthcare, BMC Medical, Wellell, Weinmann Emergency Medical, Breas Medical and SLS Medical Technology, among 18 companies covered in total.
What geographies does the Continuous Positive Airway Pressure (CPAP) Devices market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Continuous Positive Airway Pressure (CPAP) Devices?
The rise in the global prevalence of obstructive sleep apnea (OSA), largely driven by factors like obesity, aging populations, and lifestyle changes, is one of the primary factors fueling the demand for CPAP machines.
What are the main risks and barriers in the Continuous Positive Airway Pressure (CPAP) Devices market?
Noise Reduction: Manufacturers are focusing on reducing the noise levels of CPAP machines, as loud machines were a significant barrier to patient compliance.
Who should buy the Continuous Positive Airway Pressure (CPAP) Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Home Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Continuous Positive Airway Pressure (CPAP) Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.